beat365

beat·365(中国)唯一官方网站
  • 加奇生物
beat·365(中国)唯一官方网站
beat·365(中国)唯一官方网站
beat·365(中国)唯一官方网站
  • 加奇生物
You are about to leave Peijia Medical's official Chinese website.
You have just clicked on a link to another website. After clicking Continue, you may be taken to a website run by a third party. We are not responsible for the review and control of content outside Peijia Medical's official Chinese website, nor do we assume any responsibility for business transactions or matters conducted outside Peijia Medical's official Chinese website. The use of other websites is subject to the terms of use and privacy policies of those websites. Certain products or information found on other websites may not be approved for your region or country.
Cancel
Continue

A Global Service Provider of Innovative Medical Products and Solutions

Focusing on the inno

Focusing on the innovation, R&D and production of high-end medical devices for structural heart and cerebrovascular disease intervention, Peijia Medical covers the entire product pipeline for aortic, mitral and tricuspid valve replacements and related surgical instruments and accessories, as well as diseases related to hemorrhage, ischemia and access in the field of cerebrovascular intervention. It has built a domestic portfolio of products and solutions in the field of  structural heart and cerebrovascular disease.

9996.HK
Stock Code
2012Year
Duration of Existence
29
Launched Products
7
Innovation Pathway Devices
430+
Global Patents (Applied for)
800+
Hospital(SHD)
3000+
Hospital(NVU)
Moreright-row
Solutions

Adhering to the corporate vision of "Devoted to Heart, Reverence for Life", Peijia Medical strives to be a respected global high-tech medical enterprise. Staying true to our original values, we are fully focused on serving patients by providing safe, effective and affordable products and solutions. With continuous innovation, we aim to alleviate the suffering of patients and improve their quality of life. 

heart
Valvular Heart Disease
brain
Stroke
beat·365(中国)唯一官方网站
beat·365(中国)唯一官方网站 beat·365(中国)唯一官方网站
Products

Cardiovascular and cerebrovascular diseases are one of the main causes of death all year round. Peijia Medical has long been committed to developing interventional therapies for structural heart disease and cerebrovascular diseases—a field in urgent need of breakthroughs. Powered by independent innovation and the world’s latest technological developments, the Company focuses on research hotspots at the global frontier of medicine, helping patients around the world to live healthier and better lives.

Morebeat·365(中国)唯一官方网站

Company News

More beat·365(中国)唯一官方网站
Professional Education
Morebeat·365(中国)唯一官方网站
Innovation Ecosystem
Morebeat·365(中国)唯一官方网站
Top
【网站地图】